#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Use of intraoperative measurement of parathyroid hormone levels to predict the success of parathyroidectomy for primary hyperparathyroidism


Authors: F. Hanzalová 1 ;  J. Hložek 1,2 ;  J. Rotnágl 1,2 ;  J. Astl 1 3
Authors place of work: Klinika otorinolaryngologie a maxilofaciální chirurgie 3. LF UK a ÚVN Praha 1;  3. lékařská fakulta, Univerzita Karlova, Praha 2;  Katedra otorinolaryngologie, IPVZ, Praha 3
Published in the journal: Otorinolaryngol Foniatr, 73, 2024, No. 3, pp. 144-152.
Category: Original Article
doi: https://doi.org/10.48095/ccorl2024144

Summary

Introduction: Primary hyperparathyroidism is the third most common endocrine disorder, which is caused by overproduction of parathyroid hormone by hyperfunctioning parathyroid glands. Surgical removal of hyperfunctioning parathyroid glands is the definitive first-line treatment for primary hyperparathyroidism. Bilateral neck exploration has been the most frequently described approach in the literature. Due to the development of localization imaging, targeted parathyroidectomy is increasingly being approached. Many authors report the use of intraoperative measurement of parathyroid hormone levels (ioPTH) as an essential component of targeted parathyroidectomy to confirm intraoperative complete removal of all hyperfunctioning parathyroid tissue. Intraoperatively, the success of surgery is most often assessed according to the Miami criteria with a sensitivity of 97%. Aim: The aim of this study is to retrospectively analyze the perioperatively measured parathyroid hormone levels in our cohort formed between 2020 and 2023. To learn about the dynamics of parathyroid hormone levels during parathyroidectomy and to analyze with what sensitivity the definitive success of parathyroidectomy for primary hyperparathyroidism can be predicted according to the perioperative decrease in parathyroid hormone levels. Methodology and description of the cohort: The analyzed cohort includes 75 patients. The data available for this retrospective analysis are preoperative parathyroid hormone levels, perioperatively measured parathyroid hormone levels at 5th, 10th, and 15th minutes, and parathyroid hormone levels on the third postoperative day. We evaluated the perioperative decrease in parathyroid hormone according to the Miam criteria and their modifications. We evaluated the sensitivity, specificity, and accuracy with which the criteria predicted the definitive success of the operation. Results: To analyze the data, we established six criteria for measuring perioperative parathyroid hormone. The resulting criterion has a sensitivity of 98%. Conclusion: Retrospective data analysis is useful for understanding the peroperative perioperative dynamics of parathyroid hormone levels and for the informed setting of criteria to predict intraoperative surgical success.

Keywords:

monitoring – Parathyroid hormone – parathyroidectomy – intraoperative


Zdroje
1. Libánský P. Diagnostika a chirurgická léčba primární hyperparathyreózy. Autoreferát disertační práce. Praha: 1. LF UK a III. chirurgická klinika FN v Motole, Anatomický ústav 1. LF UK. Školitel: doc. MUDr. Svatopluk Adámek, CSc., 2009.
2. Šiprová H, Souček M, Šipr K. Current problems of primary hyperparathyroidism in clinical practice. Inter Med 2016; 18 (3): 134–136. Doi: 10.36290/int.2016.031.
3. Astl J, Hložek J, Holý R et al. Morbidity and mortality of parathyroid surgery – a retrospective analysis. Rozhl Chir 2021; 100 (3): 126–132. Doi: 10.33699/PIS.2021.100.3.126-132.
4. Kršek M, Čáp J, Šumník Z et al. Doporučený postup České endokrinologické společnost pro diagnostiku a léčbu primární hyperparathyreózy a hypoparathyreózy. Olomouc: Solen Medical education 2021.
5. Broulík P. Diferenciální diagnostika hyperkalcemií. Vnitr Lek 2007; 53 (7–8): 826–830.
6. Calò PG, Pisano G, Loi G et al. Intraoperative parathyroid hormone assay during focused parathyroidectomy: the importance of 20 minutes measurement. BMC Surg 2013; 18 (13): 36. Doi: 10.1186/1471-2482-13-36.
7. Khan ZF, Lew JI. Intraoperative Parathyroid Hormone Monitoring in the Surgical Management of Sporadic Primary Hyperparathyroidism. Endocrinol Metab (Seoul) 2019; 34 (4): 327–339. Doi: 10.3803/EnM.2019.34.4.327.
8. Khan AA, Khatun Y, Walker A et al. Role of intraoperative PTH monitoring and surgical approach in primary hyperparathyroidism. Ann Med Surg (Lond) 2015; 4 (3): 301–305. Doi: 10.1016/j.amsu.2015.08.007.
9. Quinn AJ, Ryan ÉJ, Garry S et al. Use of Intraoperative Parathyroid Hormone in Minimally Invasive Parathyroidectomy for Primary Hyperparathyroidism: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg 2021; 147 (2): 135–143. Doi: 10.1001/jamaoto.2020.4021.
10. Pereira C. Role of intraoperative parathyroid hormone in guiding parathyroidectomy. Acta Biomed 2023; 94 (2): e2023040. Doi: 10.23750/abm.v94i2.13998.
11. Irvin GL jr, Solorzano CC, Carneiro DM. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg 2004; 28 (12): 1287–1292. Doi: 10.1007/s00268-004-7708-6.
12. Riss P, Krall C, Scheuba C et al. Risk factors for „PTH spikes“ during surgery for primary hyperparathyroidism. Langenbecks Arch Surg 2013; 398 (6): 881–886. Doi: 10.1007/s00423- 013-1097-y.
13. Richards ML, Thompson GB, Farley DR et al. An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg 2011; 146 (3): 280–285. Doi: 10.1001/archsurg.2011.5.
14. Vaghaiwalla TM, Khan ZF, Lew JI. Review of intraoperative parathormone monitoring with the miami criterion: A 25-year experience. World J Surg Proced 2016; 6 (1): 1–7 Doi: 10.5412/wjsp.v6.i1.1.
15. Carneiro DM, Solorzano CC, Nader MC et al. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 2003; 134 (6): 973–981. Doi: 10.1016/ j.surg.2003.06.001.
16. Graceffa G, Cipolla C, Calagna S et al. Interpretation of intraoperative parathyroid hormone monitoring according to the Rome criterion in primary hyperparathyroidism. Sci Rep 2022; 12 (1): 3333. Doi: 10.1038/s41598-022-07380-4.
17. Garbutt L, Sigvaldason H, Sharaf Eldin MH et al. What is the most appropriate intraoperative baseline parathormone? A prospective cohort study. Int J Surg 2016; 25: 49–53. Doi: 10.1016/j.ijsu.2015.11.044.
ORCID autorů
F. Hanzalová 0009-0005-1687-2764,
J. Hložek 0000-0002-3584-9747,
J. Rotnágl 0000-0003-2692-0342,
J. Astl 0000-0002-8022-0200.
Přijato k recenzi: 16. 6. 2024
Přijato do tisku: 9. 8. 2024
MUDr. Františka Hanzalová
Klinika ORL a maxilofaciální chirurgie
3. LF UK a ÚVN Praha
U Vojenské nemocnice 1200
169 02 Praha 6
hanzalovafrantiska@seznam.cz
Štítky
Audiology Paediatric ENT ENT (Otorhinolaryngology)

Článok vyšiel v časopise

Otorhinolaryngology and Phoniatrics

Číslo 3

2024 Číslo 3

Najčítanejšie v tomto čísle
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#